BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 28224363)

  • 1. Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer.
    Kudou K; Saeki H; Nakashima Y; Edahiro K; Korehisa S; Taniguchi D; Tsutsumi R; Nishimura S; Nakaji Y; Akiyama S; Tajiri H; Nakanishi R; Kurashige J; Sugiyama M; Oki E; Maehara Y
    Ann Surg Oncol; 2017 Jul; 24(7):1804-1810. PubMed ID: 28224363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.
    Zheng ZF; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Huang CM
    Ann Surg Oncol; 2017 Jul; 24(7):1795-1803. PubMed ID: 28213789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Nakanishi R; Kubo N; Ando K; Oki E; Ikeda T; Maehara Y
    Am J Surg; 2019 Apr; 217(4):757-763. PubMed ID: 30005807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
    Tamandl D; Paireder M; Asari R; Baltzer PA; Schoppmann SF; Ba-Ssalamah A
    Eur Radiol; 2016 May; 26(5):1359-67. PubMed ID: 26334504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
    van der Werf LR; Wijnhoven BPL; Fransen LFC; van Sandick JW; Nieuwenhuijzen GAP; Busweiler LAD; van Hillegersberg R; Wouters MWJM; Luyer MDP; van Berge Henegouwen MI
    Ann Surg; 2019 Nov; 270(5):868-876. PubMed ID: 31634182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia is an Independent Predictor of Severe Postoperative Complications and Long-Term Survival After Radical Gastrectomy for Gastric Cancer: Analysis from a Large-Scale Cohort.
    Zhuang CL; Huang DD; Pang WY; Zhou CJ; Wang SL; Lou N; Ma LL; Yu Z; Shen X
    Medicine (Baltimore); 2016 Mar; 95(13):e3164. PubMed ID: 27043677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical and Perioperative Treatments for Esophagogastric Junction Cancer.
    Yanagimoto Y; Kurokawa Y; Doki Y
    Ann Thorac Cardiovasc Surg; 2024; 30(1):. PubMed ID: 38839368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
    Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
    Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
    Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.
    Zhuang CL; Shen X; Zou HB; Dong QT; Cai HY; Chen XL; Yu Z; Wang SL
    Clin Nutr; 2020 Jul; 39(7):2301-2310. PubMed ID: 31732287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
    Lu J; Zheng ZF; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM
    Ann Surg Oncol; 2018 Feb; 25(2):439-448. PubMed ID: 29181681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
    Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
    Wei S; Tian J; Song X; Chen Y
    Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.
    Kudou K; Saeki H; Nakashima Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    World J Surg; 2019 Apr; 43(4):1068-1075. PubMed ID: 30478682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.
    Deng HY; Zha P; Peng L; Hou L; Huang KL; Li XY
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30496385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes?
    Tseng J; Posner MC
    Ann Surg Oncol; 2020 Feb; 27(2):511-517. PubMed ID: 31571057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.